Business

HLS Therapeutics to Host Q3 Fiscal 2022 Financial Results Conference Call

HLS Therapeutics to Host Q3 Fiscal 2022 Financial Results Conference Call Canad...

articleHls Therapeutics, Inc.October 27, 20224/company/hls-therapeutics-inc/news/hls-therapeutics-to-host-q3-fiscal-2022-financial-results-conference-call
HLS Therapeutics to Host Q3 Fiscal 2022 Financial Results Conference Call

About this update from Hls Therapeutics, Inc.

[{"type":"text","content":"\n \n \n \n HLS Therapeutics to Host Q3 Fiscal 2022 Financial Results Conference Call\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prngen2{\nPADDING-RIGHT:0.17em; PADDING-LEFT:0.17em; BORDER-TOP:black 1pt; BORDER-RIGHT:black 1pt; BORDER-BOTTOM:black 1pt; BORDER-LEFT:black 1pt\n}\n.prnml4{\nMARGIN-TOP:0em; MARGIN-RIGHT:0em; MARGIN-BOTTOM:0em; MARGIN-LEFT:0.33em !IMPORTANT\n}\n.prnbcc{\nBORDER-COLLAPSE: COLLAPSE; BORDER-TOP:1pt black; BORDER-RIGHT:1pt black; BORDER-BOTTOM:1pt black; BORDER-LEFT:1pt black\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n \n TORONTO\n \n \n ,\n \n \n Oct. 27, 2022\n \n \n /CNW/ - HLS Therapeutics Inc. (\"HLS\" or the \"Company\") (TSX: HLS), announces that it will release its Q3 Fiscal 2022 financial results on\n \n Thursday, November 10, 2022\n \n . The Company will hold a conference call that same day at\n \n 8:30 a.m. ET\n \n to discuss its results. The call will be hosted by Mr.\n \n Gilbert Godin\n \n , Chief Executive Officer and Mr.\n \n Tim Hendrickson\n \n , Chief Financial Officer.\n \n Slides to accompany management's prepared remarks will be available to view via the webcast\n \n .\n \n \n \n \n \n \n \n CONFERENCE ID:\n \n \n \n \n \n \n 70968021\n \n \n \n \n \n \n \n \n DATE:\n \n \n \n \n \n \n Thursday, November 10, 2022\n \n \n \n \n \n \n \n \n TIME:\n \n \n \n \n \n \n 8:30 a.m. ET\n \n \n \n \n \n \n \n \n DIAL-IN NUMBER:\n \n \n \n \n \n \n 1-888-664-6392 or 416-764-8659\n \n \n \n \n \n \n \n \n WEBCAST LINK:\n \n \n \n \n \n \n \n https://app.webinar.net/Lj7XWoRZYo5\n \n \n \n \n \n \n \n \n \n TAPED REPLAY:\n \n \n \n \n \n \n 1-888-390-0541 or 416-764-8677\n \n \n \n \n \n \n \n \n REPLAY CODE:\n \n \n \n \n \n \n 968021\n \n \n \n \n \n \n \n The taped replay will be available for 14 days and the archived webcast will be available for 365 days.\n \n \n A link to the live audio webcast of the conference call will also be available on the events page of the investors section of HLS Therapeutics' website at\n \n www.hlstherapeutics.com\n \n . Please connect at least 15 minutes prior to the conference call to e...

More updates from Hls Therapeutics, Inc.